Cargando…
Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic Risk
Autores principales: | Naik, Sachin, Pal, Deeksha, Shukla, Shubham, Kumar, Vinod, Kumar, Ashwini, Jha, Vivekanand, Minz, Ranjana, Sethi, Jasmine, Bharati, Joyita, Divyaveer, Smita, Kumar, Vivek, Rathi, Manish, Kohli, Harbir Singh, Ramachandran, Raja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403650/ https://www.ncbi.nlm.nih.gov/pubmed/37547518 http://dx.doi.org/10.1016/j.ekir.2023.05.009 |
Ejemplares similares
-
Rituximab in Primary Membranous Nephropathy With Severe CKD
por: Naik, Sachin, et al.
Publicado: (2023) -
Poor Outcome after Hospital Discharge in Patients with ESKD and COVID-19
por: Sethi, Jasmine, et al.
Publicado: (2023) -
Long-Term Follow-Up of Cyclical Cyclophosphamide and Steroids Versus Tacrolimus and Steroids in Primary Membranous Nephropathy
por: Ramachandran, Raja, et al.
Publicado: (2021) -
Managing Active Iupus Nephritis During COVID-19 Pandemic
por: Bharati, Joyita, et al.
Publicado: (2021) -
Comparison of Two Steroid Regimens in Induction Therapy of Proliferative Lupus Nephritis: A Randomized Controlled Trial
por: Bharati, Joyita, et al.
Publicado: (2019)